AVAI OTC
Avai Bio, Inc.
1W: +2.4%
1M: +8.2%
3M: +3.5%
YTD: -68.3%
1Y: -57.0%
3Y: -84.5%
5Y: -92.1%
$0.13
+0.01 (+6.30%)
Weekly Expected Move ±19.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$74K
+3.4% ▲
Operating Income
-$2M
+28.0% ▲
Net Income
-$1M
+46.3% ▲
EPS (Diluted)
$-0.01
+63.8% ▲
EBITDA
-$1M
+48.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1M | $921K | $276K | $0 | $0 |
| YoY Growth | +69.2% | -24.1% | -70.0% | -100.0% | +0.0% |
| Cost of Revenue | $1M | $758K | $340K | $77K | $74K |
| Gross Profit | -$73K | $163K | -$64K | -$77K | -$74K |
| Gross Margin | -6.0% | 17.7% | -23.1% | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $230K | $506K | $300K | $2M | $1M |
| Operating Expenses | $230K | $506K | $300K | $2M | $1M |
| Operating Income | -$304K | -$343K | -$364K | -$2M | -$2M |
| Operating Margin | -25.0% | -37.2% | -131.6% | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$302K | -$127K | -$349K | -$2M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$302K | -$127K | -$349K | -$2M | -$1M |
| Net Margin | -24.9% | -13.7% | -126.3% | — | — |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.01 |
| EBITDA | -$246K | -$79K | -$326K | -$2M | -$1M |
| Shares Outstanding | 26M | 26M | 39M | 87M | 128M |